Company intelligence / Profile preview

Bay City Capital

San Francisco, California, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Bay City Capital is a leading global life sciences venture capital firm investing in companies developing biopharmaceuticals, medical devices, diagnostics, healthcare IT, and nutrition/agriculture innovations, with a portfolio spanning 100 companies and multiple therapeutic modalities and indications.[1][5]

Therapeutic areas: CardiovascularOphthalmologyEndocrinologyRheumatologyGastroenterologyNeurologyPulmonologyInfectious DiseasesMetabolic DisordersOtherHematologyDermatologyPsychiatryOncology
Modalities: Small moleculeMonoclonal antibodyProteinGene therapyCell therapyDeviceVaccineRNA therapyDiagnostic
Industry: Investors

Partnerships

Earlybird Health Tech FundDecheng Capital China Life Sciences USD Fund IBirchmere Ventures IIINorth American Nutrition and Agribusiness Fund

Beyond the preview

Go deeper on Bay City Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bay City Capital.

Explore the full profile